S&CO Inc. cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 7.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 94,280 shares of the exchange traded fund’s stock after selling 7,947 shares during the period. S&CO Inc. owned about 0.15% of SPDR S&P Biotech ETF worth $12,042,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also modified their holdings of the business. Financial Life Planners purchased a new position in SPDR S&P Biotech ETF in the first quarter valued at about $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $27,000. Intesa Sanpaolo Wealth Management acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at approximately $30,000. SHP Wealth Management acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at approximately $31,000. Finally, Legacy Wealth Managment LLC ID acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at approximately $32,000.
SPDR S&P Biotech ETF Trading Up 1.5%
SPDR S&P Biotech ETF stock opened at $154.26 on Friday. The stock has a market cap of $10.43 billion, a P/E ratio of 11.47 and a beta of 0.82. The stock has a 50 day moving average of $142.45 and a 200-day moving average of $132.39. SPDR S&P Biotech ETF has a 52 week low of $84.39 and a 52 week high of $165.71.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
